Brian K. Meyer
Impact in
-
- Toxic Organic Pollutants Impact
- Effects and risks of endocrine disrupting chemicals
- Pharmaceutical Science top 5%
Papers in
-
- Protein purification and stability 7
- Heat shock proteins research 2
-
- Hepatitis B Virus Studies 2
- Co-authors
- Gary H. Perdew (3 shared papers)John P. Vanden Heuvel (1 shared paper)Marilyn G. Pray-Grant (1 shared paper)Li Shi (1 shared paper)John R. Petrulis (1 shared paper)Jeffrey T. Blue (2 shared papers)Danny K. Chou (1 shared paper)Michel Awwad (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Vaccine X (2 papers)AAPS PharmSciTech (1 paper)The Lancet Infectious Diseases (1 paper)Molecular and Cellular Biology (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Brian K. Meyer
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 113
- Health, Toxicology and Mutagenesis 271
- Pharmaceutical Science 103
- Cancer Research 178
- Molecular Biology 696
- Immunology 187
Countries citing papers authored by Brian K. Meyer
This map shows the geographic impact of Brian K. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian K. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian K. Meyer more than expected).
Fields of papers citing papers by Brian K. Meyer
This network shows the impact of papers produced by Brian K. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian K. Meyer. The network helps show where Brian K. Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian K. Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 331 | |
| 2 | 2010 | 282 | |
| 3 | 1999 | 193 | |
| 4 | 2007 | 151 | |
| 5 | 2000 | 87 | |
| 6 | 2010 | 43 | |
| 7 | 2011 | 39 | |
| 8 | 2016 | 35 | |
| 9 | 2019 | 24 | |
| 10 | 2020 | 24 | |
| 11 | 2012 | 13 | |
| 12 | 2012 | 8 | |
| 13 | 2012 | 7 | |
| 14 | 2006 | 6 | |
| 15 | Impact of tubing material on the failure of product-specific bubble points of sterilizing-grade filters. | 2006 | 5 |
| 16 | 2012 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2012 | 2 |
About Brian K. Meyer
Brian K. Meyer is a scholar working on Molecular Biology, Epidemiology, Immunology, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Protein purification and stability (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Heat shock proteins research (2 papers), Hepatitis B Virus Studies (2 papers), Drug Solubulity and Delivery Systems (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (271 citations), Pharmaceutical Science (103 citations), Cancer Research (178 citations), Molecular Biology (696 citations) and Immunology (187 citations). Brian K. Meyer has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Gary H. Perdew, John P. Vanden Heuvel, Marilyn G. Pray-Grant, Li Shi, John R. Petrulis, Jeffrey T. Blue, Danny K. Chou, Michel Awwad, Satish Kumar Singh and Nataliya Afonina. Their work appears in journals such as Journal of Pharmaceutical Sciences, Vaccine X, AAPS PharmSciTech, The Lancet Infectious Diseases and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.